ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 575
    Facet Joint Ankylosis on Whole Spine Low-Dose CT in Radiographic Axial Spondyloarthritis
  • Abstract Number: 1132
    Facility-Level Variation in Biologic Disease Modifying Agents for Medicare Enrollees with Rheumatoid Arthritis
  • Abstract Number: 1584
    Factors Associated with Accrual of Damage over Time in Patients with SLE: Results from a Multinational Latin American Cohort
  • Abstract Number: 2866
    Factors Associated with Cardiac Dysfunction in a Longitudinal Follow-Up of Neonatal Lupus
  • Abstract Number: 1197
    Factors Associated with Clinical Disease Activity Index Adoption at an Academic Rheumatology Practice
  • Abstract Number: 618
    Factors Associated with Complete Spinal Fusion in Patients with Ankylosing Spondylitis
  • Abstract Number: 1618
    Factors Associated with Damage Accrual in SLE Patients with No Clinical or Serological Disease Activity
  • Abstract Number: 2330
    Factors Associated with Differing Types of Heart Failure in Patients with Rheumatoid Arthritis
  • Abstract Number: 2448
    Factors Associated with Discordance Between Patient and Rheumatologist Assessment of Disease Activity in Psoriatic Arthritis Considered in Remission
  • Abstract Number: 2560
    Factors Associated with Hydroxychloroquine Use in Systemic Lupus Erythematosus Patients with End Stage Renal Disease
  • Abstract Number: 1673
    Factors Associated with Overall and First-Year Mortality in Turkish Patients with ANCA-Associated Vasculitides: Retrospective, Multicentre Trial
  • Abstract Number: 1150
    Factors Associated with Participation in Rheumatic Disease-Related Research Among Underrepresented Populations: A Systematic Review
  • Abstract Number: 1614
    Factors Associated with Peripheral Neuropathies in Patients with Systemic Lupus Erythematosus: A Single Center Experience
  • Abstract Number: 525
    Factors Associated with Persistent Drug-free Remission in Patients with Rheumatoid Arthritis
  • Abstract Number: 344
    Factors Associated with the Disappearance of Calcifications Following Ultrasound Guided Percutaneous Lavage of Rotator Cuff Calcific Tendinopathy: A Post Hoc Analysis of a Randomized Controlled Trial
  • Abstract Number: 2685
    Factors Contributing to Capturing Positive Findings on Temporal Artery Biopsy: An Australian Experience from Two Rheumatology Referral Centers
  • Abstract Number: 2226
    Factors Contributing to Fracture in Pernicious Anemia Patients Presenting with Symptomatic Subacute Vertebral Compression Fractures
  • Abstract Number: 291
    Factors Explaining Patient Perspective in Psoriasis and Psoriatic Arthritis: The Role of Inflammation and Structural Damage Detected by Ultrasound
  • Abstract Number: 1122
    Factors Impacting Referral of Juvenile Idiopathic Arthritis Patients to a Tertiary Level Pediatric Rheumatology Center in North India
  • Abstract Number: 1578
    Factors Implicated in the Development of Early Osteonecrosis in Systemic Lupus Erythematosus
  • Abstract Number: 2051
    Factors in Achieving Serum Uric Acid Target and the Occurrence of Gouty Arthritis: A Cross-sectional Study Based on Japanese Health Insurance Claim Data
  • Abstract Number: 526
    Factors Influencing Discontinuation in Long-term RA Treatment
  • Abstract Number: 1474
    Factors Influencing the ESSPRI Index in Primary Sjögren’s Syndrome
  • Abstract Number: 293
    False Positives in the Ultrasound Diagnosis of Giant Cell Arteritis: Some Diseases Can Also Have Halo Sign
  • Abstract Number: 2724
    Farber Disease (Acid Ceramidase Deficiency): The First Natural History Study of This Rare Disease Involving Symptoms Which Can Mimic JIA
  • Abstract Number: 2690
    Fast Track Clinic (FTC) for Giant Cell Arteritis (GCA) – the United States Experience
  • Abstract Number: 2433
    Fatigue in Primary Sjögren’s Syndrome as a Manifestation of Heavier Disease Activity of Mucosa-Associated Lymphoid Tissue (MALT)
  • Abstract Number: 1337
    Fatigue Levels Are Not Associated with Inflammatory Activity, but with Subjective Outcomes: Results from a Longitudinal Study of Patients with Rheumatoid Arthritis Initiating bDMARD Therapy
  • Abstract Number: 2106
    Features of Pneumocystis Jirovecii Pneumonia in Juvenile Idiopathic Inflammatory Myopathy
  • Abstract Number: 983
    Fecal Transfer from Mice on High or Low Magnesium Diets Confers Arthritis Protection
  • Abstract Number: 1282
    Female Sex Is a Risk Factor for Failure to Achieve Remission in Polymyositis
  • Abstract Number: 460
    Fertility of Women with Rheumatoid Arthritis: Disease Activity Negatively Correlates with Serum AMH Levels
  • Abstract Number: 1975
    Fibrates as Drugs with Senolytic and Autophagic Activity for Osteoarthritis Treatment
  • Abstract Number: 217
    Fibromyalgia and Multiple Switching of Biologics in Spondylarthritis
  • Abstract Number: 2341
    Findings of Pulmonary Abnormalities on High Resolution Computed Tomography in a Cohort of Rheumatoid Arthritis Patients Without Known Lung Disease
  • Abstract Number: 923
    First Cardiovascular Event in Rheumatoid Arthritis: Do Patients with Venous Thromboembolism Have a Different Risk Profile Than Patients with Atherosclerotic Cardiovascular Disease?
  • Abstract Number: 862
    First Use of Cenerimod, a Selective sphingosine-1-phosphate 1 (S1P1) Receptor Modulator, for the Treatment of Systemic Lupus Erythematosus: A Double-Blind, Randomised, Placebo-Controlled, Phase II, Proof-of-Concept Study
  • Abstract Number: 2102
    First-line Antiretroviral Therapy with Tenofovir Produces Deleterious Effects on Bone and an Increase in Proinflammatory Cytokines Expression After 12 Months of Treatment in Naïve HIV Patients
  • Abstract Number: 2800
    Five Year Structural Changes in Patients with Meniscal Tear and Osteoarthritis from an RCT of Arthroscopic Partial Meniscectomy vs. Physical Therapy
  • Abstract Number: 2647
    Flares and Long-term Remission in Large-vessel Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-term Follow-up Study
  • Abstract Number: 1182
    Fluorescence Optical Imaging in the Diagnosis of Individuals Suspected of Arthritis Development – a Probabilistic Approach
  • Abstract Number: 77
    Flux Analysis Reveals Influence of Rab4 Expression on Mitochondrial and Pentose Phosphate Pathway Metabolism of Lupus T Cells
  • Abstract Number: 2616
    Forced Vital Capacity Trajectories for Systemic Sclerosis-associated Interstitial Lung Disease—Analysis from the University of Michigan Scleroderma Cohort
  • Abstract Number: 1969
    FOXO1 Is Required for Human Osteoclast Differentiation
  • Abstract Number: 2204
    Fragility Fractures in a Community Setting: Clinical Characteristics, Care Gaps, and Outcomes
  • Abstract Number: 1316
    Frail Patients Have Less Pain After Total Hip Replacement
  • Abstract Number: 1317
    Frail Patients Have Worse Function After Total Knee Replacement
  • Abstract Number: 325
    Frailty and Sarcopenia in Inflammatory Rheumatic Disease
  • Abstract Number: 1600
    Frailty and Sarcopenia in Women with Systemic Lupus Erythematosus
  • Abstract Number: 2460
    Frailty in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis: Data from a National Claims Database
  • Abstract Number: 2142
    Frailty in Systemic Rheumatic Diseases: A Systematic Review
  • Abstract Number: PP08
    Framework for Enhancing Patient-Physician Communication in the Context of Rare Disease
  • Abstract Number: 919
    Free Interlukin-18: A New Promising Biomarker for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome
  • Abstract Number: 558
    Frequency and Characteristics of Inflammatory Bowel Disease in Spondyloarthritis with Biological Therapy: Study of 270 Patients from the Same Center
  • Abstract Number: 2522
    Frequency and Early Prediction of Hydroxychloroquine Induced Retinopathy in SLE
  • Abstract Number: 1835
    Frequency and Predictors of Meaningful Decline in Forced Vital Capacity During Follow up оf a Large Cohort of Systemic Sclerosis Associated Pulmonary Fibrosis Patients
  • Abstract Number: 411
    Frequency and Staining Patterns of Antinuclear Antibodies in Myositis Patients Without Known Myositis-specific Autoantibodies
  • Abstract Number: 2701
    Frequency of Juvenile Idiopathic Arthritis (JIA) Subgroups and JIA-associated Uveitis Among JIA Patients Admitted to Referral Pediatric Rheumatology Clinics In TurkEy: A Retrospective Study, JUPITER
  • Abstract Number: 361
    Frequency of Allopurinol Dose Reduction in Hospitalized Patients with Gout Flares
  • Abstract Number: 408
    Frequency of Concomitant Non-aminoacyl-transfer-RNA Synthetase Autoantibodies in Patients with Antisynthetase Syndrome
  • Abstract Number: 600
    Frequency of Disease Flares Under Long-Term Anti-TNF Therapy in Patients with Early Axial Spondyloarthritis: Results from the Etanercept versus Sulfasalazine in Early Axial Spondyloarthritis Trial (ESTHER)
  • Abstract Number: 265
    Frequency of Performing Anti dsDNA Antibody in an ANA Negative Patient with Clinical Suspicion of SLE in a Single Centre Trial Before and After the Publication of National Guideline
  • Abstract Number: 2150
    Frequency of Polyautoimmunity in a Tertiary Hospital
  • Abstract Number: 281
    Frequency of Ultrasound Features of Knee Osteoarthritis and Their Association with Radiographic Features and Symptoms in a Community-Based Cohort
  • Abstract Number: 894
    Frequency, Severity and Costs of Flares Increase with Disease Severity in Newly Diagnosed Systematic Lupus Erythematous: A Real-World Cohort Study, United States, 2004–2015
  • Abstract Number: 1168
    Frequently Encountered Artifacts in Novel Application of Dual-Energy CT to Vascular Imaging: A Pilot Study
  • Abstract Number: 2889
    From a Potential Solution to Part of the Problem: Analysis of Spending and Price Trends for Brand-Name and Generic Colchicine and Other Gout Medications
  • Abstract Number: PP01
    From Diagnosis to the Establishment of the Labalaba Foundation: My Journey from Surviving to Thriving
  • Abstract Number: 1981
    Functional Differences Between Osteoclasts and Osteoclast-like Cells Differentiated from Peripheral Blood Mononuclear Cells in Patients with Rheumatoid Arthritis
  • Abstract Number: 2171
    Functional Exercise for Adults with Chronic Nonspecific Low Back Pain
  • Abstract Number: 975
    Functional Impairment of Mitf and the MiT Transcription Factor Family Dysregulates B Cell Activation and Function
  • Abstract Number: 1241
    Further Characterizing Morphea Subsets Using a Multi-center, Prospective, Cross-sectional Analysis of Morphea in Adults and Children
Jump to:  View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences